Episode Details
Back to Episodes
Ep. 12: How IBD Called The Correction – And Where It May Go With Chris Gessel
Episode 12
Published 7 years, 2 months ago
Description
This week, IBD Chief Content Officer Chris Gessel joined the podcast to discuss "vertical violations," which can be used to spot prolonged sell-offs. We also look at three stocks that are bucking the downtrend: Repligen, Anaplan and Insulet. Plus, Randy Watts of William O'Neil + Co. returns for a sponsored interview with Doug Peebles, Chief Investment Officer of Fixed Income at AllianceBernstein, about fixed income strategies. For the video version, show notes and charts, go to investors.com/podcast.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.